Australia Stock Exchange release from ATOMO DIAG : Access Bio receives FDA clearance for COVID-19 antibody test
27/06/2021 23:18
Australia Stock Exchange release from ATOMO DIAG AT1.AX : Access Bio receives FDA clearance for COVID-19 antibody test
Recent news on Atomo Diagnostics
See all newsBrief: Atomo Diagnostics Signs Agreement With Innovation Scientific
Brief: Atomo Diagnostics Ltd Appoints Cheri Walker As Interim Ceo
Brief: Atomo Diagnostics Undertakes Capital Raising To Raise Up To A$4.0 Million
Australia's Atomo Diagnostics slumps on discounted capital raising
Brief: Atomo Diagnostics Seeks Trading Halt